Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
AZYO Aziyo Biologics
4.460+0.050+1.13%
Close
01/27 16:00 ET
4.470+0.010+0.22%
Post Mkt Price 01/27 17:43 ET
High
4.810
Open
4.420
Turnover
269.89K
Low
4.420
Pre Close
4.410
Volume
58.77K
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Aziyo Biologics, Inc. (NASDAQ:AZYO) Short Interest Down 64.1% in January
Aziyo Biologics, Inc. (NASDAQ:AZYO – Get Rating) was the recipient of a large drop in short interest during the month of January. As of January 15th, there was short interest totalling 6,500 shares,
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersMinerva Surgical (NASDAQ:UTRS) stock moved upwards by 82.4% to $0.69 during Thursday's pre-market session. The company's market cap stands at $20.8 million. TC BioPharm (Holdings) (NASDAQ:TCBP)
Investors in Aziyo Biologics (NASDAQ:AZYO) Have Unfortunately Lost 38% Over the Last Year
Aziyo Biologics Sees 4Q Sales $12.5M-$12.7M >AZYO
Aziyo Biologics Sees 2022 Sales $49M-$49.2M >AZYO
Aziyo Biologics Sees 2022 Sales $49M-$49.2M >AZYO
Aziyo Biologics Announces Record Annual Net Sales in Preliminary (Unaudited) Fourth Quarter and Full Year 2022 Topline Results
SILVER SPRING, Md., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (NASDAQ:AZYO) ("Aziyo"), a biologics company with a portfolio of regenerative products aimed at improving compatibility between medical
Aziyo Biologics, Inc. (NASDAQ:AZYO) Short Interest Update
Aziyo Biologics, Inc. (NASDAQ:AZYO – Get Rating) was the target of a large growth in short interest in the month of December. As of December 15th, there was short interest totalling 15,600 shares, a
Looking Into Aziyo Biologics's Recent Short Interest
Aziyo Biologics's (NASDAQ:AZYO) short percent of float has fallen 54.05% since its last report. The company recently reported that it has 3 thousand shares sold short, which is 0.17% of all regular sh
Short Interest in Aziyo Biologics, Inc. (NASDAQ:AZYO) Drops By 55.6%
Aziyo Biologics, Inc. (NASDAQ:AZYO – Get Rating) saw a large decline in short interest in the month of November. As of November 30th, there was short interest totalling 3,200 shares, a decline of 55
Press Release: Aziyo Biologics Announces Funding of Additional $4 Million Term Loan With SWK Holdings Corporation
Aziyo Biologics Announces Funding of Additional $4 Million Term Loan with SWK Holdings Corporation Follows recent equity financing, resulting in debt and equity gross proceeds of $15.2 million SILVE
Company Overview
More
Aziyo Biologics, Inc. operates as a biotechnology company which focuses on regenerative medicine in areas such as cardiology, orthopedics and other medical specialties. It offers cardiac device envelope, vascular surgery, cardiothoracic repair, orthopedics and spine, sports medicine, dermal, and wound care. The company was founded by Kevin L. Rakin and Charles Randal Mills on August 6, 2015 and is headquartered in Silver Spring, MD.
CEO： Dr. C. Randal Mills, PhD
Market： NASDAQ
Listing Date： 10/08/2020
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet